The HRP Education & Outreach Office team is happy to provide a specific training at your request. Please let us know what type of training you are looking for by submitting this form.
View the SPS Quarterly Report (Power BI version)
FIRST Click the link above for the Power BI SPS Quarterly Report to determine if you already have access to the report.
If you are unable to reach the SPS Quarterly Report-Power BI version using the link above, please complete the form below to get access.
You will need to use your UConn Email and NetID credentials to log into the Power BI application. If you don’t know or have not activated your NetID, please visit the NetID Management webpage for assistance.
You will receive an email when your SPS Quarterly Report (Power BI version) access request has been processed.
Request access to SPS Quarterly Report (Power BI version)
| Name | Title | |
|---|---|---|
| Jen Lamontagne | Assistant Director, Business Integrations and Solutions | jennifer.lamontagne@uconn.edu |
| Paula Engler | Research Reporting Analyst and Research IT Help Desk | paula.engler@uconn.edu |
| Cyndi Guest | Faculty Accruals Specialist | cyndi.guest@uconn.edu |
| Charlie Tuttle | Oracle PL/SQL Developer/DBA and Research IT Help Desk | charlie@uconn.edu |
| Kristin Winot | Functional Analyst/Effort Reporting Specialist | kristin.winot@uconn.edu |
Effective June 1, 2025, the UConn IBC will make approved meeting minutes publicly available, by posting records on this site.
This procedure is pursuant to the provisions outlined in the NIH OSP Memorandum “Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules” (NIH Notice: NOT-OD-25-082).
In compliance with the NIH Guidelines, the IBC meeting minutes document the committee’s review of experiments that fall within the scope of Section III. Research activities not subject to the NIH Guidelines are not reflected in these records.
IBC Minutes
In accordance with state FOI and the requirements of the NIH Guidelines, only approved IBC minutes will be posted publicly. Records in draft form are not subject to public records requests. Please refer to the NIH OSP FAQs IBC Meetings and Minutes for additional details. The UConn IBC follows current NIH guidance to ensure compliance.
The Institutional Biosafety Committee (IBC) of the University of Connecticut (UConn) is committed to promoting the advancement of research and teaching activities, by ensuring that all experiments involving biological materials are conducted in full compliance with local, state, and federal regulations and guidelines. As required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), all institutions that conduct research with recombinant/synthetic nucleic acids (rsNA) and receive NIH funding, must maintain an active IBC. With the cooperative effort of Principal Investigators (PIs), the IBC conducts risk assessments for hazards associated with the use of biological materials, and promotes the safe use of such materials by enhancing lab personnel’s understanding of biosafety practices and procedures, as defined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) issued by the Centers for Disease Control and Prevention (CDC).
Pursuant to Section IV-B-2 of the NIH Guidelines, the IBC was originally established to review and approve “Experiments Covered by the NIH Guidelines”, as defined under Section III. Compliance with the NIH Guidelines is a requirement for institutions that accept NIH funding and conduct covered experiments. As such, compliance with the Guidelines is a term and condition of funding for all labs at UConn working with rsNA, regardless of funding source.
Due to increased regulations and rapid advancements in life sciences research, the scope of the IBC has evolved over time. IBC approval is required for all biological materials including but not limited to:
The IBC collaborates with Biosafety to ensure compliance with other federal and state regulations, such as Connecticut Department of Public Health (DPH), Centers for Disease Control and Prevention (CDC), Animal Plant Health Inspection Service (APHIS), etc.
If you are interested in joining an exciting committee that oversees biological research at UConn, email ibc@uconn.edu or the IBC Program Director at danielle.delage@uconn.edu.
The IBC must comprise no fewer than five members. At least two members shall not be affiliated with the institution (apart from membership on the IBC). Unaffiliated members represent the interest of the surrounding community with respect to health and protection of the environment.
UConn’s IBC consists of faculty, staff, and unaffiliated community members. All committee members contribute to the professional competency necessary to review the broad scope of research and teaching activities at the University.
Last Revised: 03/03/2025
The Institutional Biosafety Committee (IBC) of the University of Connecticut (UConn) is committed to promoting the advancement of research and teaching activities, by ensuring that all experiments involving biological materials are conducted in full compliance with local, state, and federal regulations and guidelines. As required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), all institutions that conduct research with recombinant/synthetic nucleic acids (rsNA) and receive NIH funding, must maintain an active IBC. With the cooperative effort of Principal Investigators (PIs), the IBC conducts risk assessments for hazards associated with the use of biological materials, and promotes the safe use of such materials by enhancing lab personnel’s understanding of biosafety practices and procedures, as defined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) issued by the Centers for Disease Control and Prevention (CDC).
Pursuant to Section IV-B-2 of the NIH Guidelines, the IBC was originally established to review and approve “Experiments Covered by the NIH Guidelines”, as defined under Section III. Compliance with the NIH Guidelines is a requirement for institutions that accept NIH funding and conduct covered experiments. As such, compliance with the Guidelines is a term and condition of funding for all labs at UConn working with rsNA, regardless of funding source.
Due to an increase in regulatory oversight as well as rapid advancements in life sciences research, the scope of the IBC has evolved over time, to include all work with biological materials.
IBC Registrations are required for the storage, use, or handling of biological materials.
The IBC collaborates with Biosafety to ensure compliance with other federal and state regulations, such as Connecticut Department of Public Health (DPH), Centers for Disease Control and Prevention (CDC), Animal Plant Health Inspection Service (APHIS), etc.
The IBC must comprise no fewer than five members. At least two members shall not be affiliated with the institution (apart from membership on the IBC). Unaffiliated members represent the interest of the surrounding community with respect to health and protection of the environment.
UConn’s IBC consists of faculty, staff, and unaffiliated community members. All committee members contribute to the professional competency necessary to review the broad scope of research and teaching activities at the University.
If you are interested in joining an exciting committee that oversees biological research at UConn, email ibc@uconn.edu or the IBC Program Director at danielle.delage@uconn.edu.
NIH has launched an initiative to update biosafety policies and oversight to address emerging risks from rapidly advancing science and technology. To support this effort, OSP plans to strengthen partnerships with institutional oversight bodies and reinforce the role of IBCs, aligning with other oversight committees such as IRBs and IACUCs.
NIH is requesting feedback from stakeholders (researchers, IBC members, etc.) regarding what they think should be included in a modern biosafety policy. A portal has been established for public comment on this initiative, which is linked below:
While comments submitted through the portal can relate to any aspect of biosafety oversight, NIH is particularly interested in hearing individual opinions regarding:
Be sure to follow University Policy when submitting personal comments.
Disclaimer Example: The opinions expressed are my own and do not reflect the views or positions of the University of Connecticut.
For additional information, please visit the NIH OSP website: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy#tab2/
These guidelines are intended to assist investigators who may be at risk for or have received a directive from a federal funding agency to stop, pause, terminate or otherwise prematurely end a human research study. Please contact the IRB Office if you have any questions or need assistance.
